Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 178,962 |
|
|||||
| News | - | ||||||
| Day High | 2.40 | Low High |
|||||
| Day Low | 2.28 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| AN2 Therapeutics Inc | ANTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.11 | -4.58% | 2.29 | 16:21:12 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.39 | 2.28 | 2.40 | 2.28 | 2.40 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,036 | 178,962 | US$ 2.32 | US$ 415,755 | - | 2.28 - 22.22 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:42:28 | 25 | US$ 2.36 | USD |
AN2 Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 67.81M | 29.74M | - | 0 | -64.73M | -2.18 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AN2 Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.48 | 2.52 | 2.28 | 2.39 | 98,099 | -0.19 | -7.66% |
| 1 Month | 3.23 | 3.88 | 2.28 | 3.07 | 406,747 | -0.94 | -29.10% |
| 3 Months | 19.32 | 21.40 | 2.28 | 3.89 | 529,496 | -17.03 | -88.15% |
| 6 Months | 14.38 | 22.22 | 2.28 | 6.34 | 292,794 | -12.09 | -84.08% |
| 1 Year | 8.49 | 22.22 | 2.28 | 7.14 | 185,215 | -6.20 | -73.03% |
| 3 Years | 16.85 | 23.58 | 2.28 | 8.44 | 116,374 | -14.56 | -86.41% |
| 5 Years | 16.85 | 23.58 | 2.28 | 8.44 | 116,374 | -14.56 | -86.41% |
AN2 Therapeutics Description
| AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease. |
